About Our Company
Royan TuCAGene at a Glance
Genetic Code to Remedy
Royan TuCAGene Knowledge-Based Company is a pioneering organization in the fields of genetics and biotechnology, founded in 2015 with the mission of developing innovative therapies based on genomic science. The company’s experts focus on integrating cutting-edge genetic technologies, immunovirotherapy, and bioinformatics to advance personalized and next-generation treatments aimed at combating therapy-resistant cancers. On the path toward transforming modern medicine, we concentrate on targeted therapies driven by precise biological data analysis, with the belief that every individual’s genetic code is the key to their effective treatment.
Key Areas of Activity
- Production and development of next-generation oncolytic viruses as an innovative approach in cancer virotherapy.
- Research and development in immunotherapy, molecular genetics, and targeted therapies.
- Providing specialized bioinformatics and molecular design services to researchers and healthcare centers.
- Equipped with dedicated R&D and GMP-compliant production laboratories, enabling collaboration with researchers across the country and supporting innovative projects under Contract Development and Manufacturing Organization (CDMO) models.
All activities are carried out under international GMP, GLP, and GDP standards to ensure the efficacy, safety, and quality of products and services.
Mission
Providing innovative solutions for the treatment of advanced and therapy-resistant cancers particularly glioblastoma and gastrointestinal-related cancers through the integration of targeted virotherapy and advanced bioinformatics analyses, with the aim of enhancing individual health and advancing toward personalized medicine.
Vision
To become one of the global pioneers in cancer virotherapy and personalized medicine, with a focus on innovation, instilling hope, and enhancing patients’ quality of life—a place where targeted and intelligent therapies fundamentally improve patient outcomes and push the boundaries of medical science.
Goals
1- Developing therapeutic platforms based on oncolytic viruses for the treatment of advanced tumors, particularly glioblastoma and gastrointestinal cancers.
2- Expanding advanced bioinformatics services and analyses for physicians, researchers, and healthcare centers at both national and international levels.
3- Establishing personalized medicine infrastructures based on patients’ genetic and molecular data in Iran and the region.
4- Empowering the domestic knowledge-based ecosystem through education, technology transfer, and scientific collaborations.
5- Attracting international investments and partnerships to advance research and enter global markets.
6- Consulting, designing, and establishing production sites for Advanced Therapy Medicinal Products (ATMPs) in compliance with GMP standards.
7- Designing and producing customized vectors for immune-based therapies, such as CAR-T cell therapy.
Have an innovative idea?
We reach out to researchers and innovators in knowledge-based companies, fostering collaboration and driving the future of science together.